Global Medical Fluid Bags Market Size, Opportunities And Trends, By Product Type [Dialysis Bags, Drain Bags, Blood Bags, Intravenous Bags, Others], By Material [Polyvinyl Chlo-ride (PVC), Polyolefin (PP), Thermoplastic Polyurethane (TPU), Others], By Geography - Forecasts From 2021 To 2026

Published:  Jun 2021 Report Code: KSI061610954 Pages: 127

The global medical fluid bags market is expected to grow at a compound annual growth rate of 6.08% over the forecast period to reach a market size of US$4.064 billion in 2026 from US$2.851 billion in 2020. The global demand for medical fluid bags is growing continuously due to the rising geriatric population and their susceptibility to various diseases. An increase in the prevalence of chronic diseases and higher admission rates in hospitals is also driving the global medical fluid bags market growth. However, the market growth may be restrained due to the awareness regarding the negative impact of synthetic polymers on the environment. Furthermore, due to the growing demand for home care treatment by patients across the globe, the growth of the medical fluid bags market seems sustainable. Region-wise, Europe has a significant market share while the Asia Pacific is expected to be the fastest-growing market owing to the higher incidences of chronic diseases. North America is also expected to register significant growth in the coming years because of advanced healthcare infrastructure and growing spending on advancement and innovation.

Market intelligence is presented in the form of analysis, charts, and graphics to help the clients in gaining a faster and efficient understanding of the global medical fluid bags market.

Major industry players profiled as part of the report are Baxter International Inc., Coloplast A/S, Thermo Fisher, C.R. Bard, Inc., and SIPPEX among others.

Increasing Geriatric Population

The market is expected to be driven by the growth in the number of geriatric and older people, worldwide. According to the World Health Organisation, the proportion of the global population, which is above 60 years of age is expected to increase from 12% to 22%, between the years 2015 and 2050. The number of older people, above 60 years of age, had outnumbered children below 5 years, in the year 2020. 80% of the older population would be living in lower and middle-income nations, by the year 2050. This poses a major challenge for nations, worldwide, as they had to ensure that their social and health systems, would be able to deal with this demographic shift. The report also stated that the older population is expected to be around 2 Billion, by the year 2050. The global pace of the population has been surging at an exponential rate, with high-income countries already have a significant number of older people. For instance, in Japan, approx. 30% of the population is over 60 years of age. By the middle of the century, middle-income countries like China, Chile, Iran, and the Russian Federation, are expected to have a similar population of older people, like Japan. One of the major factors that would ensure the stability to deal with the demographic shift, is healthcare expenditure. The European Union spends an average of 10% of their GDP proportion on healthcare, with countries like Germany, France and Sweden are driving the overall spending. The United States health care spending surged by approx. 4.6% to reach approx. USD 3.8 trillion, or around USD 11,582 per person, in the year 2019. The overall share of GDP related to healthcare budget or spending was around 17.7% in the year 2019. China spends around 5% of its GDP on Healthcare, and India's overall healthcare expenditure in the year 2020, was around 1.6% of its GDP. Some of the common conditions in older age are chronic obstructive pulmonary diseases, obesity, diabetes, and heart diseases. Older age also leads to the emergence of complex health problems such as urinary incontinence, frailty, cancer, which come under geriatric syndromes. These factors will play an imperative role in the growth of the medical fluid bags market, as the use of medical fluid bags is important for storing blood, drain, glucose, and other liquids. 

Increasing Chronic Diseases

The market is driven by the growth and rise in several chronic diseases such as cardiovascular diseases, obesity, and other related diseases. According to the World Health Organization, Cardiovascular diseases are the major cause of deaths, worldwide, annually. In 2016, an approx. 17.9 million, worldwide, died from cardiovascular diseases, which represented approx. 31% of global deaths. Most of these deaths were due to stroke and heart attacks. Kidney failures and the rising number of geriatric populations are some of the major drivers in the global catheter market. The Global Burden of Diseases (GBD) in its 2015 study, estimated that around 1.2 million deaths, worldwide, 18 million years of life, and 19 million disability-adjusted life years, which were lost from Cardiovascular diseases, were attributable to reduced and minimized glomerular filtration rates. The number has been rising since the year 2015, and because of the COVID-19 Pandemic, the situation has worsened in developed and developing countries. The GBD Study also estimated that 1.2 million people died from kidney failure in the year 2015, and the number has been increasing since. Furthermore, every year, an estimated number of 1.7 million people lost their lives from acute kidney injury, and an approx. 5-10 million people die from kidney diseases, every year. This is a major drive that would drive the overall market growth in the coming years. Obesity is also one of the major factors in the overall market growth. According to the World Health Organisation, worldwide obesity has seen a supplementary surge of three times, since the year 1975. In the year 2016, approx. 1.9 billion adult population, which is more than 18 years of age, were considered under the overweight category. Out of these estimated and approx. 1.9 billion, approx. 650 million were obese. Approx. 39% of adults were overweight and approx. 13% of the global adult population were obese, in the year 2016. Some of the common diseases with obesity are strokes, diabetes, and cardiovascular diseases, which would drive market growth in the coming years. Hospitals and clinics, worldwide, have been using advanced and high-quality medical fluid bags for surgery or other related operations.

Segmentation:

  • By Product Type
    •  Dialysis Bags
    •  Drain Bags
    •  Blood Bags
    •  Intravenous Bags
    •  Others
  •  By Material
    •  Polyvinyl Chloride (PVC)
    •  Polyolefin (PP)
    •  Thermoplastic Polyurethane (TPU)
    •  Others
  • By geography
    • North America
      • USA
      • Canada
      • Mexico
      • Others
    • South America
      • Brazil
      • Argentina
      • Others
    • Europe
      • UK
      • Germany
      • France
      • Italy
      • Spain
      • Others
    • Middle East and Africa
      • Saudi Arabia
      • UAE
      • Iran
      • Others
    • Asia Pacific
      • Japan
      • China
      • India
      • Australia
      • Others

Frequently Asked Questions (FAQs)

Q1. What will be the medical fluid bags market size by 2026?
A1. The global medical fluid bags market is expected to reach a total market size of US$4.064 billion by 2026.
 
Q2. What is the size of global medical fluid bags market?
A2. Medical Fluid Bags market was valued at US$2.851 billion in 2020. 
 
Q3. What are the growth prospects for medical fluid bags market?
A3. The medical fluid bags market is expected to grow at a CAGR of 6.08% over the forecast period.
 
Q4. Which region holds the largest market share in the medical fluid bags market?
A4. Region-wise, Europe has a significant share in the medical fluid bags market while the Asia Pacific is expected to be the fastest-growing market owing to the higher incidences of chronic diseases. 
 
Q5. What factors are anticipated to drive the medical fluid bags market growth?
A5. The global demand for medical fluid bags is growing continuously due to the rising geriatric population and their susceptibility to various diseases.
1. Introduction
1.1. Market Definition
1.2. Market Segmentation
 
2. Research Methodology
2.1. Research Data
2.2. Assumptions
 
3. Executive Summary
3.1. Research Highlights
 
4. Market Dynamics
4.1. Market Drivers
4.2. Market Restraints
4.3. Porters Five Forces Analysis
4.3.1. Bargaining Power of Suppliers
4.3.2. Bargaining Power of Buyers
4.3.3. The threat of New Entrants
4.3.4. Threat of Substitutes
4.3.5. Competitive Rivalry in the Industry
4.4. Industry Value Chain Analysis
 
5. Global Medical Fluid Bags Market Analysis, By Product Type (Value in US$ Million) 
5.1. Dialysis Bags
5.2. Drain Bags
5.3. Blood Bags
5.4. Intravenous Bags
5.5. Others
 
6. Global Medical Fluid Bags Market Analysis, By Material (Value in US$ Million) 
6.1. Introduction
6.2. Polyvinyl Chloride (PVC)
6.3. Polyolefin (PP)
6.4. Thermoplastic Polyurethane (TPU)
6.5. Others
 
7. Global Medical Fluid Bags Market Analysis, by Geography (Value in US$ Million) 
7.1. Introduction
7.2. North America (Value in US$ Million) 
7.2.1. North America Medical Fluid Bags Market Analysis, By Product Type, 2021 to 2026
7.2.2. North America Medical Fluid Bags Market Analysis, By Material, 2021 to 2026
7.2.3. By Country
7.2.3.1. United States
7.2.3.2. Canada
7.2.3.3. Mexico
7.2.3.4. Others
7.3. South America (Value in US$ Million)
7.3.1. South America Medical Fluid Bags Market Analysis, By Product Type, 2021 to 2026
7.3.2. South America Medical Fluid Bags Market Analysis, By Material, 2021 to 2026
7.3.3. By Country
7.3.3.1. Brazil
7.3.3.2. Argentina
7.3.3.3. Others
7.4. Europe (Value in US$ Million) 
7.4.1. Europe Medical Fluid Bags Market Analysis, By Product Type, 2021 to 2026
7.4.2. Europe Medical Fluid Bags Market Analysis, By Material, 2021 to 2026
7.4.3. By Country
7.4.3.1. UK
7.4.3.2. Germany
7.4.3.3. France
7.4.3.4. Italy
7.4.3.5. Spain
7.4.3.6. Others
7.5. The Middle East and Africa (Value in US$ Million) 
7.5.1. Middle East and Africa Medical Fluid Bags Market Analysis, By Product Type, 2021 to 2026
7.5.2. Middle East and Africa Medical Fluid Bags Market Analysis, By Material, 2021 to 2026
7.5.3. By Country
7.5.3.1. Saudi Arabia
7.5.3.2. UAE
7.5.3.3. Iran
7.5.3.4. Others
7.6. Asia Pacific (Value in US$ Million) 
7.6.1. Asia Pacific Medical Fluid Bags Market Analysis, By Product Type, 2021 to 2026
7.6.2. Asia Pacific Medical Fluid Bags Market Analysis, By Material, 2021 to 2026
7.6.3. By Country
7.6.3.1. Japan
7.6.3.2. China
7.6.3.3. India
7.6.3.4. Australia
7.6.3.5. Others
 
8. Competitive Environment and Analysis
8.1. Major Players and Strategy Analysis
8.2. Emerging Players and Market Lucrativeness
8.3. Mergers, Acquisitions, Agreements, and Collaborations
8.4. Vendor Competitiveness Matrix
 
9. Company Profiles
9.1. Baxter Technoflax
9.2. Thermo Fisher
9.3. Kawasaki Laboratories
9.4. C.R Bard
9.5. ConvaTec
9.6. Coloplast
9.7. B. Braun Medical
9.8. Pall Corporation
9.9. Smiths Medical
9.10. SIPPEX Medical Bags

Baxter Technoflax

Thermo Fisher

Kawasaki Laboratories

C.R Bard

ConvaTec

Coloplast

B. Braun Medical

Pall Corporation

Smiths Medical

SIPPEX Medical Bags

Pricing

Explore Custom Options available with this study:

  •  Request customization
  •  Buy sections of the study
  •  Buy country specific report
  •  Request excel, Historical data
  •  Subscription inquiry
  •  Request special pricing

Our Value Proposition

Analyst Support

All our studies come with 2 months of analyst support.


Confidentiality

We are in compliance with the global privacy laws.

Connect With Us